{"log_id": 5598858568961539418, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0, "average": 0.999371, "min": 0.998582}, "location": {"width": 83, "top": 149, "height": 25, "left": 244}, "words": "生殖毒性"}, {"probability": {"variance": 0, "average": 0.999985, "min": 0.999985}, "location": {"width": 26, "top": 160, "height": 26, "left": 1114}, "words": "监"}, {"probability": {"variance": 0.000218, "average": 0.994028, "min": 0.905087}, "location": {"width": 732, "top": 179, "height": 43, "left": 247}, "words": "雄性大鼠给予最大剂量180mgkg(以健康志愿者的稳态血浆浓度计,暴露量为400mg"}, {"probability": {"variance": 0, "average": 0.77127, "min": 0.77127}, "location": {"width": 32, "top": 199, "height": 25, "left": 1111}, "words": " EE"}, {"probability": {"variance": 0.000339, "average": 0.990838, "min": 0.89519}, "location": {"width": 774, "top": 225, "height": 42, "left": 207}, "words": "每日2次给药方案的1.7倍)或雌性大鼠给予45mg/kg(暴露量为400mg每日2次给药方案的"}, {"probability": {"variance": 0.000122, "average": 0.993863, "min": 0.953891}, "location": {"width": 323, "top": 279, "height": 35, "left": 209}, "words": "22倍),泊沙康唑对生育力未见影响"}, {"probability": {"variance": 0.001389, "average": 0.983323, "min": 0.814301}, "location": {"width": 728, "top": 315, "height": 43, "left": 256}, "words": "在大鼠中,泊沙康唑剂量≥27mgkg(暴露量为400mg每日2次给药方案的≥1.4倍)"}, {"probability": {"variance": 1.6e-05, "average": 0.997612, "min": 0.978487}, "location": {"width": 781, "top": 359, "height": 44, "left": 212}, "words": "可导致骨骼畸形(颅骨畸形和肋骨缺失)。在大鼠中,未观察到骨骼畸形的剂量(无效应剂"}, {"probability": {"variance": 0.002131, "average": 0.984411, "min": 0.704956}, "location": {"width": 781, "top": 405, "height": 43, "left": 212}, "words": "量)为9mgkg(暴露量为400mg每日2次给药方案的0.7倍)。在家兔中,最大剂量80mg/kg"}, {"probability": {"variance": 0.000232, "average": 0.991794, "min": 0.927547}, "location": {"width": 780, "top": 450, "height": 42, "left": 214}, "words": "下未观察到畸形。在家兔中,无效应剂量为20mg/kg,而大剂量40和80mgkg可导致吸收胎"}, {"probability": {"variance": 0.00184, "average": 0.990319, "min": 0.714405}, "location": {"width": 763, "top": 493, "height": 45, "left": 214}, "words": "增加,这些剂量产生的暴露水平分别为400mg每日2次给药方案的2.9或52倍。在家兔中"}, {"probability": {"variance": 0.000437, "average": 0.991062, "min": 0.891385}, "location": {"width": 525, "top": 542, "height": 45, "left": 217}, "words": "80mgkg剂量下可观察到雌性动物体重增量减少和窝仔数减少"}, {"probability": {"variance": 0.000108, "average": 0.995784, "min": 0.946547}, "location": {"width": 728, "top": 585, "height": 44, "left": 263}, "words": "在大鼠中进行了生殖、围产期和产后发育研究。当暴露量低于人体治疗剂量时,泊沙"}, {"probability": {"variance": 5.6e-05, "average": 0.995345, "min": 0.971657}, "location": {"width": 762, "top": 631, "height": 44, "left": 219}, "words": "康唑可导致骨骼异常和畸形、难产、孕期延长、平均每窝仔数减少以及出生后生存能力降低"}, {"probability": {"variance": 0.000588, "average": 0.991922, "min": 0.860562}, "location": {"width": 780, "top": 675, "height": 44, "left": 219}, "words": "在兔试验中,当泊沙康唑的暴露量超过治疗剂量时会产生胚胎毒性。与其它唑类抗真菌药物"}, {"probability": {"variance": 0, "average": 0.721716, "min": 0.721716}, "location": {"width": 21, "top": 709, "height": 20, "left": 971}, "words": "R"}, {"probability": {"variance": 0.000643, "average": 0.992981, "min": 0.874474}, "location": {"width": 455, "top": 727, "height": 37, "left": 223}, "words": "相同,这些生殖作用与给药影响甾体激素的生成有关"}, {"probability": {"variance": 0.057241, "average": 0.608361, "min": 0.36911}, "location": {"width": 157, "top": 711, "height": 84, "left": 902}, "words": "药"}, {"probability": {"variance": 0, "average": 0.999514, "min": 0.99927}, "location": {"width": 62, "top": 781, "height": 25, "left": 261}, "words": "致癌性"}, {"probability": {"variance": 0.001812, "average": 0.987381, "min": 0.74936}, "location": {"width": 786, "top": 810, "height": 44, "left": 262}, "words": "在为期2年给予低于最大耐受剂量的泊沙康唑的大鼠或小鼠致癌性试验中,未观察到药"}, {"probability": {"variance": 0.003342, "average": 0.984863, "min": 0.62902}, "location": {"width": 777, "top": 858, "height": 41, "left": 225}, "words": "物相关的肿瘤。在一项为期2年的致癌性试验中,大鼠经口给予泊沙康唑最大剂量为20mg/kg"}, {"probability": {"variance": 0.001552, "average": 0.983832, "min": 0.788072}, "location": {"width": 769, "top": 902, "height": 40, "left": 236}, "words": "(雌性)或30mg/kg(雄性),根据摄入高脂膳食(400mg每日2次方案)的健康志愿者中"}, {"probability": {"variance": 0.014296, "average": 0.964724, "min": 0.379244}, "location": {"width": 769, "top": 948, "height": 40, "left": 227}, "words": "的稳态AUC计算,上述剂量产生的暴露量分别为该方案的3.9或35倍。在小鼠试验中,经"}, {"probability": {"variance": 0.006791, "average": 0.977385, "min": 0.499183}, "location": {"width": 611, "top": 996, "height": 38, "left": 227}, "words": "口给药最大剂量为每日60mg/kg,暴露量为400mg每日2次方案的4.8倍"}, {"probability": {"variance": 0.000138, "average": 0.995566, "min": 0.930635}, "location": {"width": 739, "top": 1038, "height": 40, "left": 268}, "words": "其他:与其它唑类抗真菌药相同,在重复给药毒性试验中发现泊沙康唑对体激素的合"}, {"probability": {"variance": 0.024066, "average": 0.92723, "min": 0.404645}, "location": {"width": 852, "top": 1075, "height": 56, "left": 228}, "words": "成具有抑制作用。大鼠和犬毒性试验发现,当暴露量达到或者高子人治疗剂量产生肾"}, {"probability": {"variance": 0, "average": 0.999747, "min": 0.999462}, "location": {"width": 104, "top": 1141, "height": 25, "left": 230}, "words": "腺抑制作用"}, {"probability": {"variance": 0.000337, "average": 0.994478, "min": 0.890453}, "location": {"width": 689, "top": 1175, "height": 38, "left": 281}, "words": "在给药≥3个月的犬毒性试验中,当全身暴露量小于人治疗剂量暴露量时,可观察"}, {"probability": {"variance": 0.058474, "average": 0.757374, "min": 0.515561}, "location": {"width": 32, "top": 1169, "height": 34, "left": 971}, "words": "到神"}, {"probability": {"variance": 0.000259, "average": 0.993502, "min": 0.905624}, "location": {"width": 780, "top": 1221, "height": 36, "left": 231}, "words": "经元磷脂质病。在给药1年的猴毒性试验中,未观察到上述改变。在犬和猴中进行的为期12"}, {"probability": {"variance": 1.6e-05, "average": 0.997233, "min": 0.97893}, "location": {"width": 775, "top": 1267, "height": 35, "left": 234}, "words": "个月的神经毒性试验中,当全身暴露量大于人治疗剂量暴露量时,未观察到对中枢或周围神"}, {"probability": {"variance": 9e-06, "average": 0.995817, "min": 0.991732}, "location": {"width": 116, "top": 1321, "height": 24, "left": 234}, "words": "经系统的影响"}, {"probability": {"variance": 1.3e-05, "average": 0.998278, "min": 0.980557}, "location": {"width": 734, "top": 1355, "height": 34, "left": 278}, "words": "在大鼠中进行的为期2年的试验中,可观察到导致肺泡扩张和阻塞的肺磷脂质病。这些"}, {"probability": {"variance": 5e-06, "average": 0.998945, "min": 0.990096}, "location": {"width": 375, "top": 1403, "height": 34, "left": 233}, "words": "结果不一定代表在人中有功能改变的可能性"}, {"probability": {"variance": 4.1e-05, "average": 0.996299, "min": 0.966869}, "location": {"width": 715, "top": 1447, "height": 33, "left": 281}, "words": "在猴中进行的重复给药的安全药理学试验中,当全身暴露量是人治疗剂量暴露量的4"}, {"probability": {"variance": 0, "average": 0.816554, "min": 0.816554}, "location": {"width": 34, "top": 1511, "height": 21, "left": 975}, "words": "3"}], "language": 3}